Paper40568828
Enhancing therapeutic strategies and drug development for patients with kidney disease.
Tsang YP and 5 others. Expert Opin Drug Saf, 2026. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Enhancing therapeutic strategies and drug development for patients with kidney disease. Papers, record 40568828. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40568828
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Development | Major topic |
| Renal Insufficiency, Chronic | Major topic |
| Kidney Diseases | Major topic |
| Acute Kidney Injury | Major topic |
| Humans | |
| Animals | |
| Biomarkers | |
| Precision Medicine | |
| Membrane Transport Proteins | |
| Pharmaceutical Preparations | |
| Drug Repositioning |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| UH3 TR000504 | NCATS NIH HHS | United States | UH3TR000504 | PubMed | NIH RePORTER |
| UG3 TR002158 | NCATS NIH HHS | United States | UG3TR002158 | PubMed | NIH RePORTER |
| R01 HD102786 | NICHD NIH HHS | United States | R01HD102786 | PubMed | NIH RePORTER |
| UG3 TR002178 | NCATS NIH HHS | United States | UG3TR002178 | PubMed | NIH RePORTER |
| U2C TR004867 | NCATS NIH HHS | United States | U2CTR004867 | PubMed | NIH RePORTER |
References305
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19387469 | A rapid urine test for early detection of kidney injury. | Kidney Int | 2009 | https://conductscience.org/library/papers/19387469 | PubMed |
| 2 | 2045527 | Bioavailability and kinetics of cibenzoline in patients with normal and impaired renal function. | J Clin Pharmacol | 1991 | https://conductscience.org/library/papers/2045527 | PubMed |
| 3 | 26697493 | Kidney Injury Molecule-1 and Cardiovascular Diseases: From Basic Science to Clinical Practice. | Biomed Res Int | 2015 | https://conductscience.org/library/papers/26697493 | PubMed |
| 4 | 38328873 | A three-dimensional (3D) liver-kidney on a chip with a biomimicking circulating system for drug safety evaluation. | Lab Chip | 2024 | https://conductscience.org/library/papers/38328873 | PubMed |
| 5 | 19798593 | The role of osteopontin in inflammatory processes. | J Cell Commun Signal | 2009 | https://conductscience.org/library/papers/19798593 | PubMed |
| 6 | 33130235 | Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients With Type 2 Diabetes: A Randomized Trial. | Am J Kidney Dis | 2021 | https://conductscience.org/library/papers/33130235 | PubMed |
| 7 | 23945604 | Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development. | CPT Pharmacometrics Syst Pharmacol | 2013 | https://conductscience.org/library/papers/23945604 | PubMed |
| 8 | 38001784 | Inhibition of Indoxyl Sulfate-Induced Reactive Oxygen Species-Related Ferroptosis Alleviates Renal Cell Injury In Vitro and Chronic Kidney Disease Progression In Vivo. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/38001784 | PubMed |
| 9 | 28777303 | Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28777303 | PubMed |
| 10 | 37903844 | Clinical usefulness of urinary biomarkers for early prediction of acute kidney injury in patients undergoing transaortic valve implantation. | Sci Rep | 2023 | https://conductscience.org/library/papers/37903844 | PubMed |
| 11 | 17991769 | Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta. | Drug Metab Dispos | 2008 | https://conductscience.org/library/papers/17991769 | PubMed |
| 12 | 27475662 | The Economic Burden of Chronic Kidney Disease and End-Stage Renal Disease. | Semin Nephrol | 2016 | https://conductscience.org/library/papers/27475662 | PubMed |
| 13 | 27493693 | Treatment of hyperuricemia in gout: current therapeutic options, latest developments and clinical implications. | Ther Adv Musculoskelet Dis | 2016 | https://conductscience.org/library/papers/27493693 | PubMed |
| 14 | 35008998 | Carbamylated Proteins in Renal Disease: Aggravating Factors or Just Biomarkers? | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35008998 | PubMed |
| 15 | 24132209 | Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport. | Kidney Int | 2014 | https://conductscience.org/library/papers/24132209 | PubMed |
| 16 | 25664247 | Biomarkers in chronic kidney disease, from kidney function to kidney damage. | World J Nephrol | 2015 | https://conductscience.org/library/papers/25664247 | PubMed |
| 17 | 28736565 | Urinary Osteopontin Predicts Incident Chronic Kidney Disease, while Plasma Osteopontin Predicts Cardiovascular Death in Elderly Men. | Cardiorenal Med | 2017 | https://conductscience.org/library/papers/28736565 | PubMed |
| 18 | 37685924 | A Scoping Review on Biomarkers of Endothelial Dysfunction in Small Vessel Disease: Molecular Insights from Human Studies. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37685924 | PubMed |
| 19 | 23256482 | Species differences in drug transporters and implications for translating preclinical findings to humans. | Expert Opin Drug Metab Toxicol | 2013 | https://conductscience.org/library/papers/23256482 | PubMed |
| 20 | 39286490 | Efficient proximal tubule-on-chip model from hiPSC-derived kidney organoids for functional analysis of renal transporters. | iScience | 2024 | https://conductscience.org/library/papers/39286490 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42465467 | Voclosporin Preserves Mitochondrial Function Compared With Cyclosporine A in Perfused Human Proximal Tubule Microphysiological Systems. | bioRxiv | 2026 | https://conductscience.org/library/papers/42465467 | PubMed |
| 42453346 | Regulation of Renal Transporters by Pro-Inflammatory Cytokines in Human Proximal Tubular Epithelial Cells: Identification of the Perpetrator and Mechanisms. | ACS Pharmacol Transl Sci | 2026 | https://conductscience.org/library/papers/42453346 | PubMed |
| 42188001 | Regulation of Human Renal Transporters by Pregnancy-Related Hormones in Primary Proximal Tubular Epithelial Cells. | Metabolites | 2026 | https://conductscience.org/library/papers/42188001 | PubMed |
| 41394604 | Regulation of Renal Transporters by Pro-inflammatory Cytokines in Human Proximal Tubular Epithelial Cells: Identification of the Perpetrator and Mechanisms. | bioRxiv | 2025 | https://conductscience.org/library/papers/41394604 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40568828
GET https://conductscience.org/api/papers/v1/40568828/references?page=2